Surgical Science Sweden AB (publ) (STO:SUS)
51.10
-0.70 (-1.35%)
Sep 4, 2026, 5:29 PM CET
STO:SUS Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, STO:SUS stock has a consensus rating of "Strong Buy" and an average price target of kr 65.40. The average 1-year stock price forecast is 27.98% higher than the current stock price, while the lowest is kr 59.00 (+15.46%) and the highest is kr 85.00 (+66.34%).
Price Target: kr 65.40 (+27.98%)
Analyst Consensus: Strong Buy
Price Target
Chart* Price targets were last updated on Jul 24, 2026.
Analyst Ratings
The average analyst rating for STO:SUS stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Berenberg Bank | Berenberg Bank | Buy Upgrades kr 45.00 | Buy | Upgrades | kr 45.00 | -11.94% | Jul 24, 2026 |
Financial Forecast
Revenue This Year
1.02B
from 992.34M
Increased by 2.95%
Revenue Next Year
1.14B
from 1.02B
Increased by 11.13%
EPS This Year
2.23
from 1.71
Increased by 30.17%
EPS Next Year
3.07
from 2.23
Increased by 37.86%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is SEK.